These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34403682)

  • 41. Proteolysis-targeting chimera molecules targeting SHP2.
    Yu D; Zheng M; Liu Y; Chen L; Li H
    Future Med Chem; 2022 Apr; 14(8):587-600. PubMed ID: 35297283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of demethylincisterol A
    Chen C; Liang F; Chen B; Sun Z; Xue T; Yang R; Luo D
    Eur J Pharmacol; 2017 Jan; 795():124-133. PubMed ID: 27939989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors.
    Liu WS; Yang B; Wang RR; Li WY; Ma YC; Zhou L; Du S; Ma Y; Wang RL
    Bioorg Chem; 2020 Jul; 100():103875. PubMed ID: 32380342
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor.
    Yart A; Laffargue M; Mayeux P; Chretien S; Peres C; Tonks N; Roche S; Payrastre B; Chap H; Raynal P
    J Biol Chem; 2001 Mar; 276(12):8856-64. PubMed ID: 11134009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sprouty-related Ena/vasodilator-stimulated phosphoprotein homology 1-domain-containing protein (SPRED1), a tyrosine-protein phosphatase non-receptor type 11 (SHP2) substrate in the Ras/extracellular signal-regulated kinase (ERK) pathway.
    Quintanar-Audelo M; Yusoff P; Sinniah S; Chandramouli S; Guy GR
    J Biol Chem; 2011 Jul; 286(26):23102-12. PubMed ID: 21531714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment.
    Xie J; Si X; Gu S; Wang M; Shen J; Li H; Shen J; Li D; Fang Y; Liu C; Zhu J
    J Med Chem; 2017 Dec; 60(24):10205-10219. PubMed ID: 29155585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment.
    Kerr DL; Haderk F; Bivona TG
    Curr Opin Chem Biol; 2021 Jun; 62():1-12. PubMed ID: 33418513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dioscin overcome TKI resistance in EGFR-mutated lung adenocarcinoma cells via down-regulation of tyrosine phosphatase SHP2 expression.
    Wang YC; Wu DW; Wu TC; Wang L; Chen CY; Lee H
    Int J Biol Sci; 2018; 14(1):47-56. PubMed ID: 29483824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent advances in the discovery of protein tyrosine phosphatase SHP2 inhibitors.
    Kong J; Long YQ
    RSC Med Chem; 2022 Mar; 13(3):246-257. PubMed ID: 35434626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting Oncogenic Src Homology 2 Domain-Containing Phosphatase 2 (SHP2) by Inhibiting Its Protein-Protein Interactions.
    Bobone S; Pannone L; Biondi B; Solman M; Flex E; Canale VC; Calligari P; De Faveri C; Gandini T; Quercioli A; Torini G; Venditti M; Lauri A; Fasano G; Hoeksma J; Santucci V; Cattani G; Bocedi A; Carpentieri G; Tirelli V; Sanchez M; Peggion C; Formaggio F; den Hertog J; Martinelli S; Bocchinfuso G; Tartaglia M; Stella L
    J Med Chem; 2021 Nov; 64(21):15973-15990. PubMed ID: 34714648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020).
    Wu J; Zhang H; Zhao G; Wang R
    Curr Med Chem; 2021; 28(19):3825-3842. PubMed ID: 32988341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
    Day EK; Zhong Q; Purow B; Lazzara MJ
    Cancer Res; 2021 Apr; 81(8):2056-2070. PubMed ID: 33574084
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An Integrated Proteomic Strategy to Identify SHP2 Substrates.
    Zhu P; Wu X; Zhang RY; Hsu CC; Zhang ZY; Tao WA
    J Proteome Res; 2022 Oct; 21(10):2515-2525. PubMed ID: 36103635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.
    Sha F; Gencer EB; Georgeon S; Koide A; Yasui N; Koide S; Hantschel O
    Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14924-9. PubMed ID: 23980151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The tyrosine phosphatase Shp2 (PTPN11) in cancer.
    Chan G; Kalaitzidis D; Neel BG
    Cancer Metastasis Rev; 2008 Jun; 27(2):179-92. PubMed ID: 18286234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3β/β-catenin signaling.
    Ishida H; Kogaki S; Narita J; Ichimori H; Nawa N; Okada Y; Takahashi K; Ozono K
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1531-9. PubMed ID: 21803945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2).
    Hartman Z; Geldenhuys WJ; Agazie YM
    J Biol Chem; 2020 Mar; 295(11):3563-3575. PubMed ID: 32024694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small molecule inhibitors of SHP2 tyrosine phosphatase discovered by virtual screening.
    Yu ZH; Chen L; Wu L; Liu S; Wang L; Zhang ZY
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4238-42. PubMed ID: 21669525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SHP2 sails from physiology to pathology.
    Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
    Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.